LeMaitre Vascular Reddick Cholangiogram Stiffer Catheter with introducer (eIFU) REF # e2400-53
FDA Device Recall #Z-1445-2017 — Class II — February 7, 2017
Recall Summary
| Recall Number | Z-1445-2017 |
| Classification | Class II — Moderate risk |
| Date Initiated | February 7, 2017 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | LeMaitre Vascular, Inc. |
| Location | Burlington, MA |
| Product Type | Devices |
| Quantity | 250 |
Product Description
LeMaitre Vascular Reddick Cholangiogram Stiffer Catheter with introducer (eIFU) REF # e2400-53
Reason for Recall
The Contains Latex symbol was not printed onto the box label or the sterile (inner) product pouch
Distribution Pattern
Worldwide distribution. US Nationwide, AUSTRIA, BELGIUM, FRANCE, GERMANY, ITALY, LUXEMBOURG, Morocco, Saudi Arabia, Singapore, SPAIN, SWITZERLAND, UAE, and UK
Lot / Code Information
Lot Number/Ex p. Date: RED1747 2018-09 RED1754 2018-12 RED1763 2019-03 RED1770 2019-05
Other Recalls from LeMaitre Vascular, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1574-2026 | Class II | Artegraft Vascular Graft; REF#: AG740; | Feb 10, 2026 |
| Z-0289-2026 | Class II | Artegraft¿ Collagen Vascular Graft; REF: AG1015; | Sep 25, 2025 |
| Z-0034-2026 | Class II | Artegraft Collagen Vascular Grafts Model Numbe... | Sep 2, 2025 |
| Z-0072-2026 | Class II | Artegraft Collagen Vascular Graft. Model/Catal... | Aug 25, 2025 |
| Z-1751-2025 | Class II | Pruitt Occlusion Catheter. Catalog Numbers: 210... | Apr 11, 2025 |
Frequently Asked Questions
Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.